;

Tech incubator launches AI tool • What makes opioid use dangerous • FDA encourages biosimilars

Tech incubator launches AI tool • What makes opioid use dangerous • FDA encourages biosimilars

TECH COMPANY, INCUBATOR BUILD COLLABORATION MACHINE: Chicago health tech incubator Matter and life sciences intelligence company rMark Bio have launched Origin, a kind of matchmaking, artificial intelligence machine to connect startups with established health care companies. Origin, available to Matter members only, combines rMark Bio’s AI decision making with Matter’s ability to coach startups and vet potential collaborations, the companies said in a statement.

Origin recommends matches between a startup and a pharmaceutical company, health system or health payer that are vetted by Matter, and then makes the right kind of introductions between the parties, the statement said. Origin is built on Chicago-based rMark Bio’s Fabric learning platform.

admin

Read Previous

How Can the Workforce Adopt in the Era of Artificial Intelligence?

Read Next

Confused by Congress’ bills? Maybe AI can help

Leave a Reply

Your email address will not be published. Required fields are marked *